The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Poly (ADP-ribose) polymerase (PARP) inhibitors exhibit synthetic lethality in tumors with BRCA1/2 gene defects.
• The established model posits PARP inhibitors increase DNA single-strand breaks (SSBs), leading to lethal double-strand breaks (DSBs) during replication in BRCA-deficient cells.

Purpose of the Study:

• To present alternative, non-mutually exclusive models explaining the synthetic lethality between BRCA1/2 deficiency and PARP inhibitors.
• To challenge the prevailing model of PARP inhibitor action in BRCA-deficient cancers.

Main Methods:

• Discussion of proposed alternative models for PARP-BRCA synthetic lethality.
• Review of experimental evidence supporting novel mechanistic explanations.

Main Results:

• A proposed model where PARP inhibition leads to PARP-1 trapping on DNA repair intermediates, obstructing replication forks.
• An alternative model suggesting PARP's direct role in replication repair, independent of homologous recombination.

Conclusions:

• The established model for PARP inhibitor-induced synthetic lethality in BRCA-deficient cancers may be incomplete.
• PARP trapping on DNA or direct roles in replication repair offer alternative explanations for this therapeutic effect.